Form4insider filings, from the source

SEC Form 4 · accession 0001567619-18-001475

Cimarex Resolute LLC · REN

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owners
Monarch GP LLC
Director · Other
MDRA GP LP
Director · Other
Period of report
Aug 17, 2018
Accepted (ET)
Aug 20, 2018 · 4:14 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001469510

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common Stock, par value $0.0001 per share ("Common Stock")F1,F2Aug 17, 2018S328$30.87D1ISee footnotes
Common StockF3holding———2,770D
Common StockF1,F4holding———70,868ISee footnotes
Common StockF1,F5holding———543,931ISee footnotes
Common StockF1,F6holding———452,297ISee footnotes
Common StockF1,F7holding———862,721ISee footnotes
Common StockF1,F8holding———338,254ISee footnotes

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses

Remarks

Joseph Citarrella, a Managing Principal of Monarch Alternative Capital LP, serves on the board of directors of the Issuer as a representative of Monarch Alternative Capital LP. As a result, each of Monarch Alternative Capital LP, and by virtue of their control of Monarch Alternative Capital LP, MDRA GP LP and Monarch GP LLC is a "director-by-deputization" solely for purposes of Section 16 of the Exchange Act.